NRx Pharmaceuticals, Inc. today announced that management will report third quarter 2022 financial results prior to the market open on November 14, 2022.
NRx Pharmaceuticals, Inc. today announced that management will report second quarter 2022 financial results prior to the market open on August 15, 2022.
NRx Pharmaceuticals, Inc. today announced that management will report first quarter 2022 financial results prior to the market open on May 16, 2022.
NRx Pharmaceuticals, Inc. announced that management will report year end 2021 financial results prior to the market open on March 31, 2022. The company will host a conference call and webcast on March 31, 2022, 8:30AM Eastern Time to discuss its results and provide a clinical and corporate update. Management will host the call, followed by a question-and-answer period.
RADNOR, Pa., Nov 16, 2021 /PRNewswire/ — NRx Pharmaceuticals (Nasdaq: NRXP) (NRx), a clinical-stage, biopharmaceutical company, today provided a business update and financial results for the quarter ended September 30, 2021. NRx will host a conference call Tuesday morning, November 16th, at 8:30 AM Eastern Time to discuss its business update and third-quarter financial results. […]
–Company to Host Conference Call on Tuesday, November 16, 2021, at 8:30AM ET– RADNOR, Pa., Nov. 09, 2021 (GLOBE NEWSWIRE) — NRx Pharmaceuticals (NRx) (Nasdaq: NRXP), a clinical-stage, global biopharmaceutical company, today announced that management will report third-quarter 2021 financial results before the market opens on Tuesday, November 16, 2021. The Company will host a […]
